ArticleThe Lancet. Infectious diseases2021

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.

Madhumita Shrotri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.